We argue that the long-term focus on HTA's technical inputs and related processes has failed because it implicitly endorses the state's framework. It misses the importance of making a philosophical case against a system whose primary flaw is that patients are servile to the state's economic interests.
Make the case against the state's imposition of economic interests as the only consideration
January 21, 2025 Latest NewsBioPharmaCommentNews of the Day
Latest Video
New Stories
-
An institution dominated by very clever people, but where is the wisdom?
August 14, 2026 - - Latest News -
A plain language version of these dreadful and useless documents
August 14, 2026 - - Latest News -
CUREator+ backs six Australian startups with $13.5 million to advance new health technologies
August 13, 2026 - - Australian Biotech -
Medicines Australia appoints former AbbVie executive to key leadership role
August 13, 2026 - - Latest News -
VVMF and Optosleep partner to advance Australian gene therapy for sleep apnoea
August 13, 2026 - - Latest News -
Survey exposes deep gaps in neurological care across Australia
August 13, 2026 - - Latest News -
Australia 'is not an island' on pricing and we cannot be so arrogant to expect free product
August 13, 2026 - - Latest News

